Composition for Oral or Nasal Delivery of Tetanus, Diphtheria, and Pertussis Vaccine alone or in combination using Neurotoxin Associated Proteins
AssigneePrime Bio, Inc.
InventorBal Ram Singh
Life of this patent
Estimating the term…
Abstract
The present invention describes a neurotoxin associated protein from botulinum neurotoxin complex used as an oral or nasal delivery system for a vaccine. The vaccine is selected from tetanus, diphtheria and pertussis alone or in combination. Further the oral or nasal delivery of tetanus vaccine in combination with other drug molecules.
Claims40
A composition of neurotoxin associated proteins and vaccine
A process for the preparation of second generation tetanus toxoid vaccine, i.e., tetanus heavy chain comprising steps of;
- a) Induction of E. Coli culture OD600=0.5 by adding 0.2 mM IPTG
- b) Growing culture for 14-16° C. at 14 to 20 hours
- c) the cell paste suspends in 25 mM phosphate buffer containing 200 mM sodium chloride
- d) add 1% of triton −X-100 to the buffer
- e) Sonicate for a period of 3 minutes (5 sec on/off pulse) at 4° C. on cold beads.
- f) Centrifuge the culture for 60 to 90 minutes.
- g) Supernatant is collected
- h) Supernatant purified using Ni-NTA affinity column using an eluant;
- and
- i) Combine the pool which has less contaminated bands and concentrate the pool by using Centriprep-30.
A process for preparation of third generation detoxified recombinant tetanus toxoid vaccine comprising steps of;
- a. pBN3 vector was used for cloning TeTx Light chain in a BL21(DE3) strain for expression of the plasmid.
- b. Two active sites mutation, E234A and E271A, was done which corresponds to E224 and E262 of BoNT/A active sites.
- c. HC portion of TeNT was fused to construct full length tetanus neurotoxin plasmid with two active sites mutation, E234A and E271A.
- d. Purified the large band at 150 kDa protein position using Ni-NTA affinity column.
A process for the preparation of vaccine and NAPs composition comprises
- a. mixing equimolar ratio of vaccine and NAPs at pH 5.5 to 6.2
- b. Reacting at an ambient temperature for 2-3 hours
- c. 25 mM phosphate buffer of pH 5.8 containing 200 mM sodium chloride solution charged to step 2
- d. reacting above obtained reaction mixture with 10 mM imidazole solution
- e. The reaction mixture further loaded to Ni-NTA affinity column;
- and
- f. eluted the column to get the pure NAPs-vaccine composition.
Dependencies are inferred from the claim text.